Nov. 8, 2022—Vanderbilt researchers found that a protein with roles in innate immunity worsens memory at baseline in carriers of APOE-e4, the strongest genetic risk factor for Alzheimer’s disease, further implicating neuroinflammation in cognitive decline.
Nov. 4, 2022—A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age.
Nov. 3, 2022—Vanderbilt's Stacie Dusetzina, PhD, and several colleagues were able to reflect recently on the South Lawn of the White House about how their contributions through research and data informed the provisions in the Inflation Reduction Act that will save older Americans on Medicare tens of thousands of dollars in out-of-pocket costs each year.
Nov. 3, 2022—Climate and Health conversations will take place on Nov. 13 and 14, from 12:15 pm - 1 pm CT on Twitter Spaces.
Nov. 3, 2022—A team at Case Western Reserve University and Vanderbilt University Medical Center has determined with atomic-level precision how two established drugs bind to and alter the conformation of a cell membrane transporter protein called NKCC1, shutting down its activity.
Nov. 3, 2022—A new study shows engaging infants with a song provides a readymade means for supporting social development and interaction.
Nov. 3, 2022—A new Master of Imaging Science program at Vanderbilt will immerse students in the full spectrum of biomedical imaging and provide hands-on clinical and research experience.